Navigation Links
Commissions in Medical News

BTIG To Hold 7th Commissions for Charity Day

anticipated donationS to benefit local charities NEW YORK, May 18 /PRNewswire/ -- BTIG LLC, an institutional broker dealer specializing in trading and related brokerage services, will donate equity and derivative trading commission profits earned on Tuesday, May 19 to a group of nonprofit or...

AHIP Statement on New CMS Guidelines for Agent and Broker Commissions in Medicare Advantage

WASHINGTON, Nov. 10 /PRNewswire-USNewswire/ -- Karen Ignagni, President and CEO of America's Health Insurance Plans (AHIP), today issued the following statement on new guidelines announced by CMS on agent and broker compensation for Medicare Advantage plans: "We commend CMS for taking this i...

SAFC Pharma Commissions HPAPI Conjugates Facility at St. Louis

ST. LOUIS, Sept. 29 /PRNewswire-FirstCall/ -- SAFC Pharma(TM), a focus area within SAFC(R), a member of the Sigma-Aldrich Group (Nasdaq: SIAL ), today announced details of a new suite that has been commissioned at its St. Louis campus that will produce high-potency active pharmaceutical ingre...

San Antonio Community Hospital Commissions Leksell Gamma Knife(R) Perfexion(TM) To Serve Over 3 Million Californians

ATLANTA, June 3 /PRNewswire/ -- Physicians at California's San Antonio Community Hospital in Upland, will soon treat patients using the new Leksell(R) Gamma Knife Perfexion(TM). A revolutionary alternative to traditional open-brain surgery and daily radiation treatments, Leksell Gamma Knife Pe...

Chiefs Of Regional Commissions For Animal Health Announced

Dr. Robert Thwala, the Ministry of Agriculture Director of Veterinary and Livestock Services, was anointed as President of the African Regional Commission //for the International Committee of the World Organisation for Animal Health (OIE). Dr. Barry O’Neil was earlier elected the President of...

MAP Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock

...fering of 3,500,000 shares of its common stock at a public offering price of $9.70 per share. Net proceeds, after estimated underwriting discounts and commissions and estimated expenses, will be approximately $31.4 million. MAP Pharmaceuticals has granted the underwriters of the offering a 30-day option to purc...

NHP Reports 2009 Second Quarter Results

...ation 756 777 1,570 1,524 Lease commissions and tenant and capital improvements (1,343) (1,047) ... Deferred finance cost amortization 3,120 3,120 Lease commissions and tenant and capital improvements (5,608) (5,...

West Announces Second Quarter 2009 Results

... increase included additional spending on information systems, including depreciation and other project-related costs, and outside services, including commissions and acquisition-related legal services. Research spending was substantially unchanged from the prior-year quarter. Resulting operating profit was $34...

Hospira Reports Second-Quarter 2009 Results

... $402.0 $338.3 Trade accounts payable 200.4 231.5 Salaries, wages and commissions 121.2 144.7 Deferred income taxes - 1.5 Other accrued liabilities ...

Cell Therapeutics, Inc. Announces Closing of Public Offering of Common Stock and Warrants

... overallotment option. The Company received approximately $40.3 million in net proceeds from the offering, after deducting underwriting discounts and commissions and estimated offering expenses. Each warrant has an exercise price of $1.70 per warrant share, for total potential additional gross proceeds t...
Commissions in Medical Technology

Oncolytics Biotech(R) Inc. Announces Publication of Research on Synergistic Activity of Reovirus and Chemotherapy in NSCLC

...rtainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue relian...

Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours

...rtainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue relian...

Breast Cancer Clinical Results Show Test Can Differentiate Normal, Early and Later Stage Cancers

...on for our products or product candidates. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward...

Cancer Therapy & Research Center at The University of Texas Health Science Center and Oncolytics Biotech(R) Inc. Announce Multi-Trial Clinical Research Collaboration

...rtainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward looking statements. Investors are cautioned against placing undue relian...

Oncolytics Biotech Inc. Announces Start of Patient Enrolment in Translational Clinical Trial Investigating REOLYSIN(R) in Patients with Metastatic Colorectal Cancer

...rtainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward looking statements. Investors are cautioned against placing undue relian...

PreMD Inc. Enters Clinical Study with Cosmetics Conglomerate

... for our products or product candidates. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward...

AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108

... and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward...

U.S. NCI Starts Enrolment in Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN(R)

...rtainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward looking statements. Investors are cautioned against placing undue relian...

Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement

...ly market products, and other factors which may be beyond the control of either Transition or Lilly. Please see Transition's filings with the Canadian commissions and Lilly's filings with the U.S. Securities and Exchange Commission for further information about risk factors and other cautionary statements. Neith...

Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement

...n Stock at a price of $0.65 per share resulting in gross proceeds of $650,000. WestPark Capital, Inc. acted as placement agent and received $65,000 in commissions and $26,000 representing a non-accountable expense fee. Lixte also issued to WestPark five year warrants to purchase up to 100,000 shares of the Compa...
Commissions in Biological News

Britain's last Neanderthals were more sophisticated than we thought

...s south east England. The project now aims to prospect more widely across the region for similar sites. Barney Sloane, Head of Historic Environment commissions at English Heritage, said: "Sites such as this are extremely rare and a relatively little considered archaeological resource. Their remains sit at a k...

Unmanned aircraft to study Southern California smog and its consequences

...g effects for the first time over California, and this data will likely help California reduce its global warming commitment. The California Energy commissions Public Interest Energy Research (PIER) program will employ CAPPS results in an analysis of the potential future economic and ecological consequences o...

Proposal to step up cardiovascular disease research

... existing projects, and in particular the European Vascular Genomics Network (EVGN), which has been running since January 2004 as part of the European commissions FP6 framework research programme. EVGN has been promoting multidisciplinary interaction between 30 world class basic and clinical institutions in 11 E...

Tiny fish can yield big clues to Delaware River health

...e new habitats for the bridle shiner. The results of the Academys studies, which will continue into 2008, will factor into the Delaware River Basin commissions flow management plans for the river. Bridle shiner prefer slow-moving, shallow waters that flow over beds of aquatic plants. The Upper Delaware River ...
Commissions in Biological Technology

PEAT International Commissions Plasma-Based Waste Treatment Facility Designed Specifically for Onsite Waste Processing

- Marks the first deployment of the system intended for hospitals and industrial facilities - NORTHBROOK, Ill., and ANKLESHWAR, India, April 23 /PRNewswire/ -- PEAT International, Inc., ("PEAT") a global leader in plasma-based waste remediation solutions, announced toda...

Exciton Technologies receives FDA approval to market exSALT(TM)

...sequently shown to be invalid or infringe the patents of others. Investors should consult the Company's quarterly and annual filings with the Canadian commissions for additional information on risks and uncertainties relating to the forward- looking statements. Investors are cautioned against placing undue relia...

Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock

...ounced the pricing of an underwritten offering of 7,248,936 shares of its common stock at a price of $3.14 per share. After underwriting discounts and commissions and estimated offering expenses, the company expects to receive net proceeds of approximately $21.2 million. All of the shares are being sold by Iden...

AEterna Zentaris Partner, Keryx, Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial with Perifosine (KRX-0401) for the Treatment of Multiple Myeloma

... and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward...

Oncolytics Biotech(R) Inc. Announces 2009 Second Quarter Results

...general changes to the economic environment. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue relian...

Oncolytics Biotech Inc. Successfully Completes 100-Litre cGMP Production of REOLYSIN(R)

...rtainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue relian...

Orexigen(R) Therapeutics Announces Full Exercise of Overallotment Option by Underwriters

... of $7.50 per share, resulting in expected net proceeds to the company of approximately $81.6 million (after payment of the underwriting discounts and commissions and estimated expenses). Leerink Swann LLC acted as sole book-running manager for the offering. Lazard Capital Markets LLC, Canaccord Adams ...

Cell Therapeutics, Inc. Announces Exercise of Overallotment

...common stock, for aggregate gross proceeds of approximately $43.9 million. The net proceeds to the Company after deducting underwriting discounts and commissions and estimated offering expenses are expected to be approximately $40.3 million. Each warrant has an exercise price of $1.70 per warrant share...

Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement

...irstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX: ANP) today filed a preliminary short form base shelf prospectus with the securities commissions of British Columbia and Ontario and a corresponding shelf registration statement on Form S-3 with the United States Securities and Exchange Commission...

Cell Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock and Warrants

...954 additional shares of its common stock to cover overallotments, if any. The net proceeds to the Company after deducting underwriting discounts and commissions and estimated offering expenses, excluding any exercise of the underwriter's overallotment option, are expected to be approximately $35.0 million. ...
Other Tags
(Date:9/17/2014)... progressive decline in signal transduction and insulin release, according ... in Sweden. The finding, which is published in the ... underlying age-related impairment of insulin-producing cells and diabetes. , ... many diseases, and type 2 diabetes is no exception. ... of developing type 2 diabetes if their insulin-producing cells ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 The ... serving Westchester, Putnam and Dutchess Counties in New ... clinical affiliation agreement with the Mount Sinai Health ... providing integrated and coordinated care for the communities ... both Mount Sinai and MKMG will work together ...
(Date:9/17/2014)... September 17, 2014 “North America ... market data on the North America Gynecological Devices ... US dollars, volume (in units) and average prices ... Female Sterilization Devices (Transcervical Sterilization ... and Rings)) , Endometrial Ablation Devices ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Lintelus, ... announced today it has released Lintelus Meeting Version ... meetings and corporate events. The newest release includes ... and document management capabilities and allow a more ... , Lintelus Meeting 3.1 offers product advancements ...
(Date:9/17/2014)... Chesterbrook, PA (PRWEB) September 17, 2014 ... costs and increase efficiency. Today, Pharmacy Healthcare Solutions, ... Reporting, a web-based analysis and forecasting tool that ... while maximizing the impact of medications on improved ... TARxGET Reporting uses pharmacy purchase data to identify ...
Breaking Medicine News(10 mins):Health News:Mechanism behind age-dependent diabetes discovered 2Health News:Mount Sinai Health System Partners with Mount Kisco Medical Group to Enhance Health Care Options for Residents of Lower Hudson Valley 2Health News:Mount Sinai Health System Partners with Mount Kisco Medical Group to Enhance Health Care Options for Residents of Lower Hudson Valley 3Health News:Gynecological Devices Market in North America (US, Canada & Mexico) to 2020 New Report Available at MarketOptimizer.org 2Health News:Gynecological Devices Market in North America (US, Canada & Mexico) to 2020 New Report Available at MarketOptimizer.org 3Health News:Gynecological Devices Market in North America (US, Canada & Mexico) to 2020 New Report Available at MarketOptimizer.org 4Health News:Lintelus Energizes Audiences with the Latest Version Of its Multi-Screen Interactive Software 2Health News:Pharmacy Healthcare Solutions Launches TARxGET™ Reporting 2Health News:Pharmacy Healthcare Solutions Launches TARxGET™ Reporting 3
(Date:9/16/2014)... Philadelphia, PA, September 16, 2014 Schizophrenia is associated ... A growing body of research suggests that the relationship ... effort by patients to use nicotine to self-medicate symptoms ... new study, published in the current issue of ... authors found that the level of nicotine receptors in ...
(Date:9/16/2014)... are responsible for practically all vital functions in ... forward signals, transport particular substances and control immune ... proteins do not function independently of each other, ... examine the protein networks, you find many similarities ... from TUM,s Chair of Plant Systems Biology. "Some ...
(Date:9/15/2014)... microbes influence processes from digestion to disease resistance. Despite ... terrestrial ecosystems on the planet, more is known about ... Smithsonian scientists and colleagues working on Panama,s Barro Colorado ... tree were home to more than 400 different kinds ... contained more than 7,000 different kinds. , Bacteria in ...
Breaking Biology News(10 mins):Smoking and schizophrenia linked by alterations in brain nicotine signals 2Good networkers make prime targets 2Smithsonian scientists discover tropical tree microbiome in Panama 2
Other Contents